XNDX stock forecast, quote, news & analysis

Key Takeaways

• The Tradr 2X Long XNDU Daily ETF (XNDX) is a single-stock, 2x leveraged ETF (exchange-traded fund) designed to deliver twice the daily return of Xanadu Quantum Technologies, Inc. (XNDU).
• XNDX has fallen roughly 55% over the last 30 days and about 97% over the trailing quarter, with the daily reset of 2x leverage amplifying the underlying stock's decline.
• Primary catalysts include Xanadu's post-SPAC (special purpose acquisition company) de-rating, insider selling, ongoing equity dilution, and a third-quarter earnings miss.
• As a leveraged, single-issuer product with a 1.49% expense ratio and a small asset base, XNDX carries extreme volatility and compounding-decay risk.
• Quantum computing sector sentiment and Xanadu's rising research spending remain the dominant investment themes influencing the fund.
• For additional detail on this ticker, explore its Price Targets and Forecast pages.
• Explore Trending AI Robots for AI-driven market insights.

Tradr 2X Long XNDU Daily ETF (XNDX) Overview and Portfolio Exposure

XNDX is a leveraged, single-stock ETF that seeks daily investment results, before fees and expenses, equal to 200% of the daily performance of Xanadu Quantum Technologies, a Canadian developer of photonic quantum computing hardware and software. Rather than tracking a diversified index or sector, the fund concentrates its exposure in one issuer through a small number of positions — typically the underlying shares plus a total-return swap — so its entire return profile is driven by XNDU's price action.

The fund launched in May 2026 and carries a net expense ratio of 1.49%. Assets under management (AUM) remain small, generally in the low single-digit millions of dollars. Because the 2x objective resets daily, returns held for more than one session can diverge materially from two times the cumulative return of the underlying stock; in a persistent downtrend, this daily reset compounds losses and generates volatility decay. This structure explains why the ETF has fallen far more than twice the decline of XNDU over the quarter.

Tradr 2X Long XNDU Daily ETF (XNDX) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, XNDX declined approximately 55%, moving from around $0.65 to a recent close near $0.29. The move was not range-bound or gradual; it was a persistent, trend-driven slide punctuated by sharp single-day swings consistent with a leveraged product tracking a volatile single stock.

The quarterly picture is even more severe. About three months ago the fund traded near $10.50; it has since fallen roughly 97% to under $0.30. The underlying stock, XNDU, declined about 28% over the last 30 days and roughly 80% over the quarter, and the fund's 2x daily leverage — combined with compounding — magnified those losses on the way down.

What Drove XNDX Price in the Last 30 Days

The 30-day move was driven almost entirely by Xanadu Quantum Technologies, the fund's sole underlying holding. XNDU declined after reporting third-quarter results, with revenue of about $1.3 million missing consensus estimates of roughly $2.2 million and a net loss of $0.11 per share coming in wider than expected. Research and development (R&D) spending rose about two-thirds year over year to roughly $25.6 million, well above quarterly revenue.

The earnings miss compounded a longer-running overhang: Xanadu's shares have been pressured by insider and institutional selling and by dilution from an at-the-market equity facility after its SPAC listing. Because XNDX adds 2x daily leverage on top of a falling underlying, each down day in XNDU translated into a roughly doubled loss in the fund, while the daily reset eroded value further during rebounds.

What Drove XNDX Performance Over the Last Quarter

The quarterly decline reflects a broader de-rating of speculative quantum computing names and of Xanadu specifically. After a sharp post-listing rally that took the shares well above their merger reference price, XNDU gave back the gains as investors reassessed the company's multi-year path to commercial, fault-tolerant quantum computing and its limited near-term revenue.

Persistent capital-raising and share dilution, together with a rotation out of pre-revenue growth and quantum hardware names, kept sustained selling pressure on XNDU through the quarter. For XNDX, the daily 2x reset turned that gradual decline into a far larger cumulative drawdown, illustrating why leveraged single-stock ETFs are structured for short-term tactical use rather than buy-and-hold positions.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that lets investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. Rather than reviewing tickers one at a time, users can screen for trending names, breakout candidates, and specific setups across sectors and investment themes. The tool is designed to make research more efficient and to surface opportunities that manual screening might miss. Investors can explore the AI Screener to apply these filters to their own watchlists and strategies.

XNDX ETF Outlook: What Investors Should Watch Next

Going forward, XNDX's trajectory will continue to track Xanadu Quantum Technologies closely, with 2x leverage amplifying moves in both directions. Key factors include Xanadu's cash runway — roughly $286.5 million at the end of the third quarter — against a rising research budget, and the risk of further dilution from its available equity facility. Progress toward its roadmap of up to 200 logical qubits by 2029, partnerships with manufacturers such as GlobalFoundries (GFS), ASML (ASML), and Advanced Micro Devices (AMD), and non-dilutive Canadian government funding are potential positive catalysts.

Investors should also monitor broader risk appetite for pre-revenue quantum and growth technology names, which has been a defining driver of sector volatility. For the fund itself, the daily reset and volatility decay mean that outcomes over weeks and months depend heavily on the path of the underlying stock, not just its starting and ending levels. XNDX remains a high-risk, tactical instrument whose outlook is inseparable from Xanadu's commercialization timeline and financing decisions.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations